We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

116 hedge funds and large institutions have $66.6M invested in Sanofi Contingent Value Rights in 2015 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 14 increasing their positions, 21 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 11

1% more funds holding

Funds holding: 115 → 116 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

10% less capital invested

Capital invested by funds: $74M → $66.6M (-$7.42M)

33% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 21

Holders
116
Holders Change
+1
Holders Change %
+0.87%
% of All Funds
3.13%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
14
Reduced
21
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EM
Elliott Management
New York
+$7.32M
2
MCM
Moore Capital Management
New York
+$685K
3
DAM
Deltec Asset Management
New York
+$598K
4
PWAM
Park West Asset Management
California
+$423K
5
CPA
Columbia Pacific Advisors
Washington
+$164K

Top Sellers

Rank Fund Capital Flow
1
FTCM
Fir Tree Capital Management
New York
-$12.9M
2
Allianz Asset Management
Allianz Asset Management
Germany
-$4.09M
3
LCM
Lonestar Capital Management
California
-$1.24M
4
CCA
Catalyst Capital Advisors
New York
-$203K
5
Millennium Management
Millennium Management
New York
-$142K
Name Holding Trade Value Shares
Change 		Change in
Stake
TL
26
TowerView LLC
New York
$270K -$6.92K -10,000 -3%
Goldman Sachs
27
Goldman Sachs
New York
$210K +$11.4K +16,528 +6%
TI
28
Telemetry Investments
New York
$204K +$143K +206,004 +242%
CPA
29
Columbia Pacific Advisors
Washington
$166K +$164K +237,625 New
BCM
30
Basso Capital Management
Connecticut
$154K -$17.3K -25,000 -10%
FRM
31
Fore Research & Management
New York
$134K – – –
YCM
32
Yakira Capital Management
Connecticut
$115K – – –
EEG
33
E.E. Geduld
$105K +$34.6K +50,000 +50%
First Eagle Investment Management
34
First Eagle Investment Management
New York
$102K – – –
UBS Group
35
UBS Group
Switzerland
$89K +$22.9K +33,044 +35%
ZIG
36
Zuckerman Investment Group
Illinois
$72K – – –
PP
37
Paloma Partners
Connecticut
$70K – – –
Wells Fargo
38
Wells Fargo
California
$63K -$888 -1,283 -1%
JP Morgan Chase
39
JP Morgan Chase
New York
$61K +$25.8K +37,311 +75%
CAS
40
CTC Alternative Strategies
Illinois
$53.1K – – –
GI
41
GAMCO Investors
Connecticut
$50K -$1.61K -2,331 -3%
IRF
42
IBM Retirement Fund
New York
$49K – – –
Citadel Advisors
43
Citadel Advisors
Florida
$49K +$14.1K +20,451 +42%
ACA
44
Anchor Capital Advisors
Massachusetts
$42K – – –
KAM
45
Knightsbridge Asset Management
California
$41K – – –
KAM
46
Kazazian Asset Management
Florida
$36K -$3.38K -4,892 -9%
Commonwealth Equity Services
47
Commonwealth Equity Services
Massachusetts
$36K +$2.15K +3,104 +6%
Korea Investment Corp
48
Korea Investment Corp
South Korea
$35K – – –
OCM
49
Osterweis Capital Management
California
$35K – – –
Morgan Stanley
50
Morgan Stanley
New York
$31K -$467 -675 -2%
1
2
3 4 5

GCVRZ Hedge Fund Activity: Q2 2015 in Review

116 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q2 2015, worth a combined $66.6M — down 10% from $74M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new GCVRZ positions and 11 closed out — a net gain of 4 holders — while 14 added to existing stakes and 21 trimmed.

The largest buyer was Elliott Management, adding an estimated $7.32M. The largest seller was Fir Tree Capital Management, exiting entirely with an estimated $12.9M sold.

  • 116 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q2 2015, up from 115 in Q1 2015.
  • Funds reported $66.6M of Sanofi Contingent Value Rights stock for Q2 2015, down 10% quarter-over-quarter.
  • 15 funds opened new Sanofi Contingent Value Rights positions in Q2 2015 and 11 closed out, a net change of +4 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q2 2015 was Elliott Management, an estimated $7.32M added.
  • The largest Sanofi Contingent Value Rights seller in Q2 2015 was Fir Tree Capital Management, an estimated $12.9M sold.

Based on aggregated 13F filings for Q2 2015.